# Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

> **NCT05774561** · — · RECRUITING · sponsor: **The Institute of Molecular and Translational Medicine, Czech Republic** · enrollment: 480 (estimated)

## Conditions studied

- Cervical Cancer
- Cervical Dysplasia
- Oropharyngeal Cancer
- Human Papillomavirus Infection

## Interventions

- **DIAGNOSTIC_TEST:** Arm A - Diagnostic test: HPV detection in liquid biopsies
- **DIAGNOSTIC_TEST:** Arm B - Diagnostic test: HPV detection in liquid biopsies

## Key facts

- **NCT ID:** NCT05774561
- **Lead sponsor:** The Institute of Molecular and Translational Medicine, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-12-01
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05774561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05774561, "Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05774561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*